Credit: Pixabay/CC0 Public Domain Studies of mouse models of Fragile X syndrome and Phelan-McDermid syndrome show that treatment with cannabidiol (CBD) and the diabetes drug metformin can alleviate behavioral difficulties,…
Tag: Medications
Subcutaneous infusion of levodopa-carbidopa beneficial for Parkinson’s disease
Subcutaneous infusion of ND0612 (a levodopa-carbidopa solution) increases on time without troublesome dyskinesia among patients with Parkinson disease, according to a study published online March 15 in The Lancet Neurology.…
Ticagrelor monotherapy cuts bleeding risk in acute coronary syndrome
Treatment with ticagrelor alone results in a lower rate of clinically relevant bleeding compared with ticagrelor and aspirin among patients with an acute coronary syndrome who had percutaneous coronary intervention…
Lab tests show THC potency inflated on retail marijuana in Colorado
Credit: Unsplash/CC0 Public Domain Cannabis flower sold in Colorado claims to contain much more tetrahydrocannabinol, or THC, than it actually does, according to my findings published in the peer-reviewed journal…
Mimicking exercise with a pill
Credit: Unsplash/CC0 Public Domain Doctors have long prescribed exercise to improve and protect health. In the future, a pill may offer some of the same benefits as exercise. Now, researchers…
What patients need to know
Opill, the first-ever over-the-counter birth control pill, will be available in major retailers. Credit: Perrigo The first over-the-counter (OTC) birth control pill, Opill, will be available at pharmacies, convenience stores,…
Significant proportion of cancer drugs lack proof of added benefit, finds study
Credit: CC0 Public Domain Many cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved through expedited (“fast track”)…
New cell-based immunotherapy offered for melanoma
Credit: Pixabay/CC0 Public Domain Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, is one of the first centers nationwide to offer a…
Trial data underpins FDA approval of omalizumab for food allergy
Credit: Unsplash/CC0 Public Domain Today’s Food and Drug Administration approval of a supplemental biologics license for the monoclonal antibody omalizumab (Xolair) highlights the vital role of the National Institutes of…
